132 related articles for article (PubMed ID: 29150918)
1. Central Role of Transforming Growth Factor Type Beta 1 in Skeletal Muscle Dysfunctions: An Update on Therapeutic Strategies.
Abrigo J; Simon F; Cabrera D; Cordova G; Trollet C; Cabello-Verrugio C
Curr Protein Pept Sci; 2018; 19(12):1189-1200. PubMed ID: 29150918
[TBL] [Abstract][Full Text] [Related]
2. MiR-206 Attenuates Denervation-Induced Skeletal Muscle Atrophy in Rats Through Regulation of Satellite Cell Differentiation via TGF-β1, Smad3, and HDAC4 Signaling.
Huang QK; Qiao HY; Fu MH; Li G; Li WB; Chen Z; Wei J; Liang BS
Med Sci Monit; 2016 Apr; 22():1161-70. PubMed ID: 27054781
[TBL] [Abstract][Full Text] [Related]
3. HMGB1/autophagy pathway mediates the atrophic effect of TGF-β1 in denervated skeletal muscle.
Yang X; Xue P; Liu X; Xu X; Chen Z
Cell Commun Signal; 2018 Dec; 16(1):97. PubMed ID: 30526602
[TBL] [Abstract][Full Text] [Related]
4. The role of TGF-β1 during skeletal muscle regeneration.
Delaney K; Kasprzycka P; Ciemerych MA; Zimowska M
Cell Biol Int; 2017 Jul; 41(7):706-715. PubMed ID: 28035727
[TBL] [Abstract][Full Text] [Related]
5. Satellite Cell-Derived Exosomes: A Novel Approach to Alleviate Skeletal Muscle Atrophy and Fibrosis.
Liu H; Yuan S; Liu G; Li J; Zheng K; Zhang Z; Zheng S; Yin L; Li Y
Adv Biol (Weinh); 2024 Apr; 8(4):e2300558. PubMed ID: 38329214
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.
Painemal P; Acuña MJ; Riquelme C; Brandan E; Cabello-Verrugio C
Biofactors; 2013; 39(4):467-75. PubMed ID: 23460581
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
[TBL] [Abstract][Full Text] [Related]
9. Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy.
Narola J; Pandey SN; Glick A; Chen YW
PLoS One; 2013; 8(11):e79356. PubMed ID: 24244485
[TBL] [Abstract][Full Text] [Related]
10. Customized platelet-rich plasma with transforming growth factor β1 neutralization antibody to reduce fibrosis in skeletal muscle.
Li H; Hicks JJ; Wang L; Oyster N; Philippon MJ; Hurwitz S; Hogan MV; Huard J
Biomaterials; 2016 May; 87():147-156. PubMed ID: 26923362
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy.
Abrigo J; Rivera JC; Simon F; Cabrera D; Cabello-Verrugio C
Cell Signal; 2016 May; 28(5):366-376. PubMed ID: 26825874
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Dysfunction in Skeletal Muscle Pathologies.
Abrigo J; Simon F; Cabrera D; Vilos C; Cabello-Verrugio C
Curr Protein Pept Sci; 2019; 20(6):536-546. PubMed ID: 30947668
[TBL] [Abstract][Full Text] [Related]
13. Lack of Smad3 signaling leads to impaired skeletal muscle regeneration.
Ge X; Vajjala A; McFarlane C; Wahli W; Sharma M; Kambadur R
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E90-102. PubMed ID: 22535746
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation.
Ábrigo J; Simon F; Cabrera D; Cabello-Verrugio C
Cell Physiol Biochem; 2016; 40(1-2):27-38. PubMed ID: 27842312
[TBL] [Abstract][Full Text] [Related]
16. Heat stress promotes extracellular matrix remodelling via TGF-β1 and MMP-2/TIMP-2 modulation in tenotomised soleus and plantaris muscles.
Hirunsai M; Srikuea R; Yimlamai T
Int J Hyperthermia; 2015 Jun; 31(4):336-48. PubMed ID: 25677837
[TBL] [Abstract][Full Text] [Related]
17. Role of transforming growth factor-β1 in the process of fibrosis of denervated skeletal muscle.
Fanbin M; Jianghai C; Juan L; Yang W; Yuxiong W; Yanhua C; Tao L; Zhenbing C
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):77-82. PubMed ID: 21336728
[TBL] [Abstract][Full Text] [Related]
18. Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy.
Chen H; Qian Z; Zhang S; Tang J; Fang L; Jiang F; Ge D; Chang J; Cao J; Yang L; Cao X
Redox Biol; 2021 Jan; 38():101774. PubMed ID: 33152664
[TBL] [Abstract][Full Text] [Related]
19. Secreted Frizzled-Related Protein 2 and Inflammation-Induced Skeletal Muscle Atrophy.
Zhu X; Kny M; Schmidt F; Hahn A; Wollersheim T; Kleber C; Weber-Carstens S; Fielitz J
Crit Care Med; 2017 Feb; 45(2):e169-e183. PubMed ID: 27661566
[TBL] [Abstract][Full Text] [Related]
20. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury.
Shen W; Li Y; Zhu J; Schwendener R; Huard J
J Cell Physiol; 2008 Feb; 214(2):405-12. PubMed ID: 17657727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
